| Dolutegravir plus two different prodrugs of tenofovir to treat HIV WDF Venter, M Moorhouse, S Sokhela, L Fairlie, N Mashabane, ... New England Journal of Medicine 381 (9), 803-815, 2019 | 572 | 2019 |
| Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial S Delany-Moretlwe, JP Hughes, P Bock, SG Ouma, P Hunidzarira, ... The Lancet 399 (10337), 1779-1789, 2022 | 251 | 2022 |
| Adult antiretroviral therapy guidelines 2017 G Meintjes, MA Moorhouse, S Carmona, N Davies, S Dlamini, ... Southern African journal of HIV medicine 18 (1), 1-24, 2017 | 236 | 2017 |
| Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial … WDF Venter, S Sokhela, B Simmons, M Moorhouse, L Fairlie, ... The lancet HIV 7 (10), e666-e676, 2020 | 203 | 2020 |
| HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: results from a prospective observational demonstration project R Eakle, GB Gomez, N Naicker, R Bothma, J Mbogua, ... PLoS medicine 14 (11), e1002444, 2017 | 155 | 2017 |
| Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study LE Hermans, M Moorhouse, S Carmona, DE Grobbee, LM Hofstra, ... The Lancet infectious diseases 18 (2), 188-197, 2018 | 143 | 2018 |
| Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infection LG Bekker, K Rebe, F Venter, G Maartens, M Moorhouse, F Conradie, ... Southern African journal of HIV medicine 17 (1), 2016 | 105 | 2016 |
| CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz R Griesel, G Maartens, M Chirehwa, S Sokhela, G Akpomiemie, ... Clinical Infectious Diseases 73 (11), e3902-e3909, 2021 | 75 | 2021 |
| Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase MJ Siedner, MA Moorhouse, B Simmons, T de Oliveira, R Lessells, ... Nature communications 11 (1), 5922, 2020 | 65 | 2020 |
| Southern African HIV Clinicians Society guidelines for antiretroviral therapy in adults: 2020 update MB Mulaudzi, JF Woods, WDF Venter, C van Vuuren, H van der Plas, ... Southern African Journal of HIV Medicine 21 (1), 2020 | 55 | 2020 |
| Adult antiretroviral therapy guidelines 2014: guideline G Meintjes, J Black, F Conradie, V Cox, S Dlamini, J Fabian, G Maartens, ... Southern African Journal of HIV Medicine 15 (4), 121-143, 2014 | 51 | 2014 |
| Virological suppression and clinical management in response to viremia in South African HIV treatment program: a multicenter cohort study LE Hermans, S Carmona, M Nijhuis, HA Tempelman, DD Richman, ... PLoS medicine 17 (2), e1003037, 2020 | 47 | 2020 |
| Cutting the cost of South African antiretroviral therapy using newer, safer drugs WDF Venter, B Kaiser, Y Pillay, F Conradie, GB Gomez, P Clayden, ... SAMJ: South African Medical Journal 107 (1), 28-30, 2017 | 47 | 2017 |
| Third-line antiretroviral therapy program in the South African public sector: cohort description and virological outcomes M Moorhouse, G Maartens, WDF Venter, MY Moosa, K Steegen, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 80 (1), 73-78, 2019 | 44 | 2019 |
| South African HIV self-testing policy and guidance considerations F Venter, M Majam, L Jankelowitz, S Adams, M Moorhouse, S Carmona, ... Southern African journal of HIV medicine 18 (1), 2017 | 43 | 2017 |
| A descriptive analysis of the role of a WhatsApp clinical discussion group as a forum for continuing medical education in the management of complicated HIV and TB clinical … J Woods, M Moorhouse, L Knight Southern African journal of HIV medicine 20 (1), 1-9, 2019 | 42 | 2019 |
| Southern African guidelines on the safe, easy and effective use of pre-exposure prophylaxis: 2020 LG Bekker, B Brown, D Joseph-Davey, K Gill, M Moorhouse, ... Southern African journal of HIV medicine 21 (1), 1-8, 2020 | 28 | 2020 |
| Progressive rises in weight and clinical obesity for TAF/FTC/DTG and TDF/FTC/DTG versus TDF/FTC/EFV: ADVANCE and NAMSAL trials A Hill, F Venter, E Delaporte, S Sokhela, C Kouanfack, M Moorhouse, ... 10th International Antiviral Society Conference on HIV Science, Mexico City …, 2019 | 28 | 2019 |
| Guidelines to support HIV-affected individuals and couples to achieve pregnancy safely: update 2018 NECG Davies, G Ashford, LG Bekker, N Chandiwana, D Cooper, SJ Dyer, ... Southern African Journal of HIV Medicine 19 (1), 1-26, 2018 | 28 | 2018 |
| Phase 3 trials of new antiretrovirals are not representative of the global HIV epidemic T Pepperrell, A Hill, M Moorhouse, P Clayden, K McCann, S Sokhela, ... Journal of Virus Eradication 6 (2), 70-73, 2020 | 24 | 2020 |
